Sangamo Therapeutics, Inc. (SGMO) Social Stream
SANGAMO THERAPEUTICS INC (SGMO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SANGAMO THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 9 | $25 | $11 | $17.875 | $1.76 | 915.62% |
| 2021-12-14 | 9 | $25 | $9 | $17.5 | $1.76 | 894.32% |
| 2022-01-06 | 9 | $25 | $9 | $17.428 | $1.76 | 890.23% |
| 2022-02-08 | 8 | $25 | $6 | $16.857 | $1.76 | 857.78% |
| 2022-02-25 | 8 | $25 | $6 | $16.571 | $1.76 | 841.53% |
| 2022-04-01 | 8 | $25 | $6 | $16.428 | $1.76 | 833.41% |
| 2022-04-05 | 7 | $25 | $6 | $15.857 | $1.76 | 800.97% |
| 2022-05-06 | 7 | $25 | $6 | $15 | $1.76 | 752.27% |
| 2022-05-09 | 7 | $25 | $6 | $14.833 | $1.76 | 742.78% |
| 2022-05-10 | 7 | $25 | $4.4 | $14.566 | $1.76 | 727.61% |
| 2022-06-08 | 7 | $25 | $4.4 | $13.066 | $1.76 | 642.39% |
| 2022-08-05 | 7 | $25 | $4.4 | $12.233 | $1.76 | 595.06% |
| 2022-11-03 | 7 | $25 | $5 | $12 | $1.76 | 581.82% |
| 2022-12-16 | 8 | $25 | $4 | $12.857 | $1.76 | 630.51% |
| 2023-01-04 | 8 | $25 | $4 | $12.142 | $1.76 | 589.89% |
| 2023-02-08 | 8 | $25 | $4 | $11.714 | $1.76 | 565.57% |
| 2023-02-23 | 9 | $25 | $4 | $11.875 | $1.76 | 574.72% |
| 2023-02-26 | 9 | $25 | $4 | $11.525 | $1.76 | 554.83% |
| 2023-02-27 | 9 | $25 | $4.2 | $13.025 | $1.76 | 640.06% |
| 2023-02-28 | 9 | $25 | $4.2 | $12.9 | $1.76 | 632.95% |
| 2023-03-03 | 9 | $16 | $4.2 | $11.65 | $1.76 | 561.93% |
The Trend in the Analyst Price Target
SGMO's average price target has moved down $9.95 over the prior 33 months.
SGMO reports an average of 216.46% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-05 | 7 | 25 | 4.4 | 12.233 | 5.20 | 135.25% |
| 2022-08-07 | 7 | 25 | 5.0 | 12.000 | 5.20 | 130.77% |
| 2022-08-31 | 7 | 25 | 5.0 | 12.000 | 5.40 | 122.22% |
| 2023-02-06 | 8 | 25 | 4.0 | 11.714 | 3.46 | 238.55% |
| 2023-02-08 | 8 | 25 | 4.0 | 11.714 | 3.14 | 273.06% |
SGMO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.56 | 6 | 1 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 17 months, SGMO's average broker recommendation rating improved by 0.53.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SGMO as an investment opportunity.
- SGMO has a higher upside potential (average analyst target price relative to current price) than 2169.04% of all US stocks.
- SANGAMO THERAPEUTICS INC's variance in analysts' estimates is lower than -2038.56% of all US stocks.
- In terms of how SANGAMO THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 385.85% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SANGAMO THERAPEUTICS INC's number of analysts covering the stock is higher than 1414.58% of them.
Stocks similar to SANGAMO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCEL, BCRX, and ENZN.
View All Top Stocks by Price Target
Is SGMO a Buy, Hold or Sell? See the POWR Ratings now!